SEC Form D private-offering filing

BlueWhale Bio, Inc.

A new SEC Form D private-offering notice from Philadelphia, PA, a $15,000,000 filer-stated offering target in Biotech. The source filing is one click away.

BlueWhale Bio, Inc. site↗ Verified via SEC Form D

Penn spinout developing manufacturing technology to accelerate cell based therapies, including a nanoparticle platform for CAR engineered immune cell activation and expansion

Filed 2025-10-16Filed to raise $15,000,000First money in 2025-10-10Raised so far $5,000,000HQ (as filed) Philadelphia, PASector Biotech Stage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified bluewhale.bio↗Named in the filing 5 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.